GoodRx Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
GoodRx Holdings, Inc. (GDRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $3.01 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-02-26
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-09-30 was $4.24, a 76.54% decline year-over-year.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-06-30 was $4.53, a 42.90% increase year-over-year.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-03-31 was $10.92.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-09-30 was $18.07, a 8.86% increase year-over-year.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $3.01, a 36.63% decline from fiscal 2024.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $4.75, a 28.38% increase from fiscal 2023.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $3.70, a 31.61% decline from fiscal 2022.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $5.41, a 71.24% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.01 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $4.75 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $3.70 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $5.41 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $4.24 10-Q · filed 2022-11-09 | $5.41 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $4.53 10-Q · filed 2022-08-09 | $6.03 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | $10.92 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $18.81 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $18.07 10-Q · filed 2021-11-12 | $18.07 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $3.17 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | $4.23 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $16.60 10-Q · filed 2021-11-12 | $4.23 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $3.04 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $2.95 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | $1.27 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $1.17 10-K · filed 2021-03-12 |